1. Home
  2. ADV vs PROK Comparison

ADV vs PROK Comparison

Compare ADV & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advantage Solutions Inc.

ADV

Advantage Solutions Inc.

HOLD

Current Price

$40.36

Market Cap

438.2M

ML Signal

HOLD

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.65

Market Cap

359.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADV
PROK
Founded
1987
2015
Country
United States
United States
Employees
73000
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.2M
359.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ADV
PROK
Price
$40.36
$1.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$45.83
$7.40
AVG Volume (30 Days)
97.2K
981.4K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$893,000.00
Revenue This Year
$0.63
N/A
Revenue Next Year
$0.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1075.00
52 Week Low
$0.49
$0.54
52 Week High
$46.80
$7.13

Technical Indicators

Market Signals
Indicator
ADV
PROK
Relative Strength Index (RSI) 59.44 41.23
Support Level $0.93 $1.55
Resistance Level $43.50 $2.59
Average True Range (ATR) 3.14 0.12
MACD -0.30 -0.01
Stochastic Oscillator 61.77 11.43

Price Performance

Historical Comparison
ADV
PROK

About ADV Advantage Solutions Inc.

Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: